Table 1.
Patient characteristics at the diagnosis.
| Variable | N = 124 (%) |
|---|---|
| Median age (range) | 30 (18–59) |
| Female | 75 (60) |
| ECOG performance status ≥ 2 | 82 (66) |
| ECOG performance status ≥ 3 | 21 (17) |
| CS I + II | 77 (62) |
| CS III | 10 (8) |
| CS IV | 37 (30) |
| Extranodal involvement | 42 (34) |
| Lungs | 27 (22) |
| Chest wall | 7 (5.6) |
| Kidney | 3 (2.4) |
| Ovary | 3 (2.4) |
| Bone marrow | 2 (1.6) |
| Central nervous system | 1(0,8) |
| Pleural effusion | 42 (34) |
| Pericardial effusion | 36 (29) |
| Superior vena cava syndrome | 52 (42) |
| Extranodal sites > 1 | 4 (3) |
| LDH > ULN | 107 (86) |
| LDH > 3 × ULN | 33(27) |
| IPI score 1 | 34 (27) |
| IPI score 2 | 60 (48) |
| IPI score 3 | 26 (22) |
| IPI score 4 | 4 (3) |
| Bulky tumor > 10 mm Max diameter (range) in mm | 103 (83)117 (50–300) |
LDH dehydrogenase lactate, ECOG Eastern Cooperative Oncology Group, IPI international prognostic index, ULN upper limit of normal.